NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
01/23/2018
Back to search
Official data from USPTO
PHARMASOLVE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
01/23/2018
Classification
Registered
Trademark type
Word
Nice classes
1
Filing date
05/06/2008
Registration date
12/16/2008
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/23/2018
Last transaction
01/23/2018
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
11/09/1993
First use in commerce
11/09/1993
Drawing code
4
Owner type
16
Owner location
WILMINGTON, DE
Examiner
SAITO, KIM
Law office
L20
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
ISP INVESTMENTS LLC
ISP Investments Inc.
Representatives
ISP INVESTMENTS LLC
Technical classification
Nice Classes
Class 1
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemical agent for use as a processing aid or reaction solvent in the manufacture of drugs and as a drug solubilizing or transdermal penetration agent in the formulation of drug compositions
Publications
History of USPTO decisions and trademark events.
26 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
01/23/2018
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
01/23/2018
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/23/2018
E89R
TEAS SECTION 8 & 9 RECEIVED
12/28/2017
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/28/2017
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
12/16/2017
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
07/19/2017
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
09/21/2016
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
01/04/2015
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
01/04/2015
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/04/2015
E815
TEAS SECTION 8 & 15 RECEIVED
12/12/2014
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/18/2013
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
03/27/2013
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
09/21/2011
R.PR
REGISTERED-PRINCIPAL REGISTER
12/16/2008
PUBO
PUBLISHED FOR OPPOSITION
09/30/2008
DOCK
ASSIGNED TO EXAMINER
09/29/2008
NPUB
NOTICE OF PUBLICATION
09/10/2008
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
08/28/2008
ALIE
ASSIGNED TO LIE
08/28/2008
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/19/2008
DOCK
ASSIGNED TO EXAMINER
08/18/2008
MPMK
NOTICE OF PSEUDO MARK MAILED
05/10/2008
NWAP
NEW APPLICATION ENTERED
05/09/2008
Continuous trademark protection
Get notified about every new filing that threatens PHARMASOLVE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.